GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $65.50 $83.89 Friday, 19th Apr 2024 AXSM stock ended at $67.90. This is 3.32% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 4.03% from a day low at $65.50 to a day high of $68.14.
90 days $65.50 $98.40
52 weeks $55.03 $98.40

Historical Axsome Therapeutics prices

Date Open High Low Close Volume
2023-09-14 $77.12 $78.47 $74.89 $76.20 871 210
2023-09-13 $82.03 $83.30 $76.52 $76.98 838 299
2023-09-12 $80.38 $82.39 $80.14 $82.21 420 994
2023-09-11 $80.97 $81.18 $79.74 $80.60 499 210
2023-09-08 $81.34 $82.30 $80.44 $80.65 465 377
2023-09-07 $81.79 $82.15 $80.36 $81.42 348 842
2023-09-06 $78.68 $81.59 $78.39 $81.53 380 884
2023-09-05 $81.17 $81.76 $78.58 $78.77 842 765
2023-09-01 $81.64 $82.18 $79.31 $81.69 661 677
2023-08-31 $79.99 $81.60 $79.51 $80.80 554 162
2023-08-30 $78.35 $79.75 $77.81 $79.66 516 688
2023-08-29 $78.99 $79.94 $78.26 $78.39 438 947
2023-08-28 $76.82 $79.60 $76.70 $79.17 535 836
2023-08-25 $75.40 $78.16 $74.85 $76.66 541 787
2023-08-24 $76.09 $76.52 $74.98 $75.40 439 677
2023-08-23 $76.43 $78.04 $75.46 $75.52 527 042
2023-08-22 $71.99 $76.10 $71.93 $76.06 1 114 724
2023-08-21 $70.79 $71.99 $70.08 $71.17 320 006
2023-08-18 $68.50 $71.42 $68.26 $70.78 634 384
2023-08-17 $70.99 $71.28 $68.94 $69.25 593 695
2023-08-16 $71.00 $71.73 $69.89 $70.52 422 037
2023-08-15 $71.69 $72.78 $70.44 $71.36 593 282
2023-08-14 $69.28 $72.43 $67.52 $71.65 709 803
2023-08-11 $70.50 $70.80 $69.12 $69.60 768 265
2023-08-10 $70.00 $72.39 $69.87 $70.50 835 773
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT